27 mar: São Paulos hemmelige hus
28 mar: BMW 6-serie Gran Coupé.
27-03-2012 09:50:27

Spar Nord Bank A/S completes fully subscribed rights issue

Relateret indhold
04 dec - 
64 banker i stor aftale om at sælge Nets-rivals løsning..
01 nov - 
Onsdagens aktier: Novo svingede sig i plus på fortumlet..
01 nov - 
Onsdagens aktier: Novo svingede sig i plus på fortumlet..
Relateret debat
30 nov - 
For foerste gang i lang tid har Anonymous vaeret nettok..
30 nov - 
Lyder som en god plan, jeg har også Pandora og Spar Nor..
30 nov - 
spar nord er faldet godt 20 % siden i sommer grundet fl..

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR

INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN

WHICH THE DISTRIBUTION OR RELEASE IS UNLAWFUL.

Spar Nord Bank A/S completes

fully subscribed rights issue

Spar Nord Bank A/S (the “Bank” or ”Spar Nord”) has today completed the

offering of shares with pre-emptive rights for the Bank’s existing shareholders

pursuant to the prospectus dated 5 March 2012. The offering was fully

subscribed, with 57,068,810 new shares of nominally DKK 10.

lang="EN-GB" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt">

As is usually the case for this type of issues, a small number of rights

were not exercised, for which reason 0.2 % of the shares were subscribed for by

the underwriters.

For a description of the offering, reference is made to company

announcement no. 9 dated 5 March 2012.

style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt">

Proceeds of DKK 913

million

The new shares were subscribed for at a price of DKK 16 per new share of

nominally DKK 10, and thus the offering has generated gross proceeds for Spar

Nord of DKK 913.1 million, corresponding to DKK 837.7 million in net proceeds

after deduction of estimated costs in connection with the offering.

Share capital, voting rights and

ISIN code

The capital increase was registered today with the Danish Business

Authority, and the new shares will then have the same rights as Spar Nord’s

existing shares, including the right to dividends and voting

rights.

After registration of the 57,068,810 new shares of nominally DKK 10 each,

Spar Nord’s nominal share capital amounts to DKK 1,141,376,200, divided into

114,137,620 shares of nominally DKK 10, which corresponds to 114,137,620 voting

rights.

In accordance with applicable disclosure obligations, Spar Nord hereby

discloses that the above will also apply at the end of March 2012.

The temporary ISIN code for the new shares (DK0060416048) is expected to

be merged with the ISIN code for the existing shares (DK0060036564) on NASDAQ

OMX Copenhagen on 29 March 2012.

Carnegie Bank A/S and Danske Bank A/S have acted as Joint Global

Coordinators & Bookrunners in connection with the offering.

lang="EN-GB" style="font-family: Verdana, Geneva, sans-serif; font-size: 10pt">

Sincerely yours,

Spar Nord Bank A/S

Contacts:

Lasse Nyby, Chief Executive Officer, tel.: (+45) 96 34 40 11

Ole Madsen, Senior Vice President, Corporate Communications, tel.: (+45)

96 34 40 10

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Novo-rival spår effekt af ugentligt GLP-1 på linje med Ozempics

13-12-2017 13:30:09
Novo Nordisks store franske rival Sanofi forudser, at dens ugentlige GLP-1-analog, Efpeglenatid, har en effekt på langtidsblodsukkeret, der er på linje Novos nye ugentlige diabetes 2-middel Ozempic, som tilhører samme lægemiddelklasse.Det fremgår af en præsentation under et analytikerarrangement onsdag, hvor Sanofi fremlægger sin forsknings- og udviklingsstrategi for de kommende år.Sanofi indledte..

Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

13-12-2017 09:56:25
Novo Nordisks store franske rival, Sanofi, vil ligesom Novo i de kommende år også fokusere på udviklingen af fedmemedicin og medicin til behandling af leversygdommen, NASH.Det fremgår af en pressemeddelelse i forbindelse med et analytikerarrangement onsdag, hvor Sanofi vil præsentere sin forsknings- og udviklingsstrategi for de kommende år.Sanofis udviklingsindsats inden for forretningsområdet, di..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas får sin største ordre nogensinde i Indien - NY
2
Vestas rykker nærmere kæmpekontrakter i New Mexico og Texas
3
Aktier/tendens: Genmab og Vestas fortsætter i fokus
4
Vestas ejer mere end 5 pct. egne aktier efter opkøb
5
Onsdagens aktier: Genmab endnu engang til bunds i negativt marked

Relaterede aktiekurser

Spar Nord Bank A/S 70,35 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
14. december 2017 03:26:03
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB4 - 2017-12-14 03:26:03 - 2017-12-14 03:26:03 - 1 - Website: OKAY